Blue Crest Capital Management LTD Vertex Pharmaceuticals Inc Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $464,287 - $623,589	-2,785 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $462,950 - $521,045	2,785 New	2,785 $472,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $278,906 - $352,897	-1,836 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $949,687 - $1.09 Million	-5,662 Reduced 75.51%	1,836 $354,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $1.09 Million - $1.27 Million	7,498 New	7,498 $1.27 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $9.55 Million - $11.2 Million	-63,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $8.65 Million - $9.8 Million	63,000	63,000 $9.44 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.